Degenerative neurological and neuromuscular disease

Keyphrases

Publications

volume 13, 2023

Dejan Jakimovski, Taylor R Wicks, Niels Bergsland, Michael G Dwyer, Bianca Weinstock-Guttman, Robert Zivadinov
Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis. Degenerative neurological and neuromuscular disease 13 (2023)
Dejan Jakimovski, Taylor R Wicks, Niels Bergsland, Michael G Dwyer, Bianca Weinstock-Guttman, Robert Zivadinov
Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis. Degenerative neurological and neuromuscular disease 13 (2023)
Petra Prinssen, Peter Joseph Jongen, Marco Heerings, Elia Wyverkens, Guy T'Sjoen, Ellen Deschepper, Marieke Dewitte
Sexual Motivation in Persons with Multiple Sclerosis: A Controlled Cross-Sectional Study. Degenerative neurological and neuromuscular disease 13 (2023)
Jing Ma, Yi-Hui Hou, Zhe-Yan Liao, Zheng Ma, Xiao-Xuan Zhang, Jian-Li Wang, Yun-Bo Zhu, Hai-Lei Shan, Ping-Yue Wang, Cheng-Bo Li, Ying-Lei Lv, Yi-Lan Wei, Jie-Zhi Dou
Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer's Disease Mouse Model: Role of Microglial and Neuroinflammation. Degenerative neurological and neuromuscular disease 13 (2023)
Narmadhaa Sivagurunathan, Priyadharshini Gnanasekaran, Latchoumycandane Calivarathan
Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson's Disease: What We Know so Far. Degenerative neurological and neuromuscular disease 13 (2023)
Alberto Javier-Ormazábal, Pablo Herrero Gallego, Montserrat González-Platas
Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report. Degenerative neurological and neuromuscular disease 13 (2023)
Narmadhaa Sivagurunathan, Priyadharshini Gnanasekaran, Latchoumycandane Calivarathan
Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson's Disease: What We Know so Far. Degenerative neurological and neuromuscular disease 13 (2023)
Erin Faraclas
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking Points. Degenerative neurological and neuromuscular disease 13 (2023)
Alberto Javier-Ormazábal, Pablo Herrero Gallego, Montserrat González-Platas
Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report. Degenerative neurological and neuromuscular disease 13 (2023)
Ahmed Bamaga, Lama Alqarni
Risk of Obstructive Sleep Apnea in Saudi Male Boys with Duchenne Muscular Dystrophy (DMD). Degenerative neurological and neuromuscular disease 13 (2023)

volume 12, 2022

Sidharth Mehan, Sonalika Bhalla, Ehraz Mehmood Siddiqui, Nidhi Sharma, Ambika Shandilya, Andleeb Khan
Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration. Degenerative neurological and neuromuscular disease 12 (2022)
Serena Ruggieri, Maria Esmeralda Quartuccio, Luca Prosperini
Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data. Degenerative neurological and neuromuscular disease 12 (2022)
Hiroshi Nishimune, Kimberly G Stanford, Jie Chen, James D Odum, Alexander D Rorie, Robert S Rogers, Joshua L Wheatley, Paige C Geiger, John A Stanford
Forelimb Resistance Exercise Protects Against Neuromuscular Junction Denervation in the SOD1-G93A Rat Model of ALS. Degenerative neurological and neuromuscular disease 12 (2022)
Alaina N Elliott-Wherry, Jennifer E Lee, Amy M Pearlman, Terry L Wahls
The Wahls Behavior Change Model for Complex Chronic Diseases: A Clinician's Guide. Degenerative neurological and neuromuscular disease 12 (2022)
Wilfried Kuhn, Georg Karp, Thomas Müller
No Vitamin D Deficiency in Patients with Parkinson's Disease. Degenerative neurological and neuromuscular disease 12 (2022)
Fei Fan, Fei Han, Long Hao
Mechanisms of Action of Semen Ziziphi spinosae in the Treatment of Tourette Syndrome. Degenerative neurological and neuromuscular disease 12 (2022)
Sisay Deme, Dheeraj Lamba, Abayneh Alamer, Haimanot Melese, Sileshi Ayhualem, Dechassa Imeru, Tsegereda Abebe
Effectiveness of Respiratory Muscle Training on Respiratory Muscle Strength, Pulmonary Function, and Respiratory Complications in Stroke Survivors: A Systematic Review of Randomized Controlled Trials. Degenerative neurological and neuromuscular disease 12 (2022)
Stuart H Isaacson, Sagari Betté, Rajesh Pahwa
Istradefylline for OFF Episodes in Parkinson's Disease: A US Perspective of Common Clinical Scenarios. Degenerative neurological and neuromuscular disease 12 (2022)
Hussen Abdu, Girma Seyoum
Sex Differences in Stroke Risk Factors, Clinical Profiles, and In-Hospital Outcomes Among Stroke Patients Admitted to the Medical Ward of Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. Degenerative neurological and neuromuscular disease 12 (2022)
Alberto Javier-Ormazábal, Montserrat González-Platas, Elena González-Sierra, Marta González-Sierra
Invasive Physiotherapy as a Treatment of Spasticity: A Systematic Review. Degenerative neurological and neuromuscular disease 12 (2022)
Ramón Villaverde-González
Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy. Degenerative neurological and neuromuscular disease 12 (2022)

volume 11, 2021

Abayneh Alamer, Haimanot Melese, Kefale Getie, Sisay Deme, Molla Tsega, Sileshi Ayhualem, Gebremeskel Birhanie, Yohannes Abich, Asmare Yitayeh Gelaw
Effect of Ankle Joint Mobilization with Movement on Range of Motion, Balance and Gait Function in Chronic Stroke Survivors: Systematic Review of Randomized Controlled Trials. Degenerative neurological and neuromuscular disease 11 (2021)
Samah Labban, Fahad S Alshehri, Maher Kurdi, Yasser Alatawi, Badrah Saeed Alghamdi
Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer's Disease. Degenerative neurological and neuromuscular disease 11 (2021)
Nafaa Alzobaidi, Huma Quasimi, Nasr A Emad, Abdulsalam Alhalmi, Maaz Naqvi
Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia. Degenerative neurological and neuromuscular disease 11 (2021)
Johann Lechner, Volker von Baehr, Fabian Schick
RANTES/CCL5 Signaling from Jawbone Cavitations to Epistemology of Multiple Sclerosis - Research and Case Studies. Degenerative neurological and neuromuscular disease 11 (2021)
Linda Azevedo Kauppila, Daniela Pimenta Silva, Joaquim J Ferreira
Clinical Utility of Opicapone in the Management of Parkinson's Disease: A Short Review on Emerging Data and Place in Therapy. Degenerative neurological and neuromuscular disease 11 (2021)
Maher Kurdi, Aysha Alshareef, Ahmed K Bamaga, Zahir T Fadel, Moafaq S Alrawaili, Sahar Hakamy, Fawaz Mohamed, Ahmad R Abuzinadah, Bassam M J Addas, Nadeem Shafique Butt
The Assessment of Major Histocompatibility Complex (MHC) Class-I Expression in Different Neuromuscular Diseases. Degenerative neurological and neuromuscular disease 11 (2021)

volume 10, 2020

volume 9, 2019

William F Kaemmerer, Richard C Grondin
The effects of huntingtin-lowering: what do we know so far? Degenerative neurological and neuromuscular disease 9 (2019)
Trajche Ivanovski, Francesc Miralles
Lambert-Eaton Myasthenic syndrome: early diagnosis is key. Degenerative neurological and neuromuscular disease 9 (2019)
Stephanie L Barnes, Neil G Simon
Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis. Degenerative neurological and neuromuscular disease 9 (2019)
Giancarlo Garuti, Fabrizio Rao, Viviana Ribuffo, Valeria A Sansone
Sialorrhea in patients with ALS: current treatment options. Degenerative neurological and neuromuscular disease 9 (2019)
Jill Rasmussen, Haya Langerman
Alzheimer's Disease - Why We Need Early Diagnosis. Degenerative neurological and neuromuscular disease 9 (2019)
Nicoletta L Lilli, Delphine Révy, Sandra Robelet, Béatrice Lejeune
Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson's disease. Degenerative neurological and neuromuscular disease 9 (2019)
Shaila D Ghanekar, Wai Wai Miller, Colin J Meyer, Kevin J Fenelon, Alvin Lacdao, Theresa A Zesiewicz
Orphan Drugs In Development For The Treatment Of Friedreich's Ataxia: Focus On Omaveloxolone. Degenerative neurological and neuromuscular disease 9 (2019)
Marge Kartau, Jussi O T Sipilä, Eeva Auvinen, Maarit Palomäki, Auli Verkkoniemi-Ahola
Progressive Multifocal Leukoencephalopathy: Current Insights. Degenerative neurological and neuromuscular disease 9 (2019)
Hans-Klaus Goischke
Comorbidities in multiple sclerosis-a plea for interdisciplinary collaboration to improve the quality of life of MS patients. Degenerative neurological and neuromuscular disease 9 (2019)
Jessica Costello, Annete Njue, Matthew Lyall, Anne Heyes, Nancy Mahler, Michael Philbin, Tara Nazareth
Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials. Degenerative neurological and neuromuscular disease 9 (2019)

volume 9, 2018

Thomas Müller
Editorial announcing PubMed indexing of Degenerative Neurological and Neuromuscular Disease. Degenerative neurological and neuromuscular disease 9 (2018)

volume 8, 2018

Alper Dai, Osman Baspinar, Ahmet Yeşilyurt, Eda Sun, Çiğdem İnci Aydemir, Olga Nehir Öztel, Davut Unsal Capkan, Ferda Pinarli, Abdullah Agar, Erdal Karaöz
Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy - Phase I-II. Degenerative neurological and neuromuscular disease 8 (2018)
Giuseppe Fiorentino, Anna Annunziata, Anna Michela Gaeta, Maurizia Lanza, Antonio Esquinas
Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives. Degenerative neurological and neuromuscular disease 8 (2018)
Giuseppe Preziosi, Ayeshah Gordon-Dixon, Anton Emmanuel
Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies. Degenerative neurological and neuromuscular disease 8 (2018)
Vanina Dal Bello-Haas
Physical therapy for individuals with amyotrophic lateral sclerosis: current insights. Degenerative neurological and neuromuscular disease 8 (2018)
Alexey N Boyko, Olga V Boyko
Cladribine tablets' potential role as a key example of selective immune reconstitution therapy in multiple sclerosis. Degenerative neurological and neuromuscular disease 8 (2018)
Lavanya Vijayasingham, Fatima Fanna Mairami
Employment of patients with multiple sclerosis: the influence of psychosocial-structural coping and context. Degenerative neurological and neuromuscular disease 8 (2018)
Cristina Al-Khalili Szigyarto, Pietro Spitali
Biomarkers of Duchenne muscular dystrophy: current findings. Degenerative neurological and neuromuscular disease 8 (2018)
Luca Prosperini, Letizia Castelli
Spotlight on postural control in patients with multiple sclerosis. Degenerative neurological and neuromuscular disease 8 (2018)